Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HIPEC with cisplatin in AYA with DSRCT and other non-carcinomas
NCT01277744Phase 2Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- May 2011
- Primary completion
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cisplatin in desmoplastic small round cell tumor (DSRCT), ovarian germ cell tumor (OGCT), sarcoma, Wilms' tumor, sponsored by University of Texas MD Anderson Cancer Center. Started May 2011; status: completed.
02
Drugs
cisplatin
03
Conditions
desmoplastic small round cell tumor (DSRCT)ovarian germ cell tumor (OGCT)sarcomaWilms' tumor
Beyond the preview
Go deeper on NCT01277744.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01277744.